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M
ental, neurological, and substance use (MNS)
disorders accounted for 10% of the global
burden of disease (GBD) in 2010 (1), yet on
average, mental health accounts for less than 1% of
national health budgets in Africa and South East Asia
(2). In South Africa, as in many low- or middle-income
countries (LMICs), the burden of mental disorders has
grown over the past 20 years (19902010) (1). This rise
is expected to continue, in part due to the ongoing
epidemiological transition from communicable to non-
communicable diseases (NCDs) (3) and co-morbidity be-
tween MNS disorders, HIV, and other chronic health
conditions (46).
In 2011, faced with this growing burden, South Africa’s
Ministry of Health publically committed to increasing
by 30% the number of people screened and treated for
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mental disorders by 2030, and to reducing by 20% per
capita alcohol consumption by 2020 (5, 7, 8). Health
budgets and system designs, however, do not currently
reflect these new commitments. For example, the District
Specialist Teams introduced under the proposed national
health insurance provide key specialty services to supple-
ment primary health care at the district-level, but the
teams do not include mental health providers (9). Better
understanding of cost-effective, context-specific interven-
tions or packages of interventions for treatment and
prevention of MNS disorders may contribute to achiev-
ing South Africa’s ambitious mental health targets.
Economic data is one of several relevant factors, in-
cluding burden of disease and equity, that policymakers
and donors consider as they set priorities and make
spending choices in resource-limited settings. Economic
data provides an ‘external frame’ that can be used to
make comparisons between competing priorities or in-
terventions and justify investment in programs (10, 11).
Cost-effectiveness analyses (CEAs), which compare inter-
ventions to determine those likely to yield the most im-
provements in health per dollar (12), have achieved notable
successes as an advocacy tool for system improvements
(13, 14).
Despite the importance of economic information in
advocating for and designing policy change, there are
no reviews of costs related to MNS disorders and cost-
effectiveness of their treatment in South Africa, and few
reviews that examine costing aspects of MNS disorders
in any LMICs (2). Compiling the disparate information
on costs and cost-effectiveness at a country-level could
facilitate identification of key needs, interventions, and
knowledge gaps. A health system approach, which goes
beyond single disorders or interventions, is necessary
because MNS disorders often occur together and may be
co-morbid with other health conditions, and a holistic
view can inform the design of treatment packages (15).
Mental health care in South Africa differs from that
in other LMICs, making a South Africa-specific review
necessary. Although South Africa’s gross national income
(GNI) bears greater similarity to other middle-income
countries than to the rest of sub-Saharan Africa, find-
ings on MNS disorders from middle-income nations,
including those in Latin American or South East Asia,
cannot be generalized to South Africa. South Africa
has a unique post-apartheid socioeconomic and cultural
context of inequality, with one of the highest Gini co-
efficients globally (a statistical measure of income
inequality in a population) (16), and particular disparities
between rural and urban areas. It also has a complex
disease burden characterized by high HIV prevalence
and a growing burden of non-communicable chronic
conditions (17).
Given the paucity of economic assessments of mental
health in sub-Saharan Africa and the specific challenges
facing South Africa’s mental health system, this review
summarizes current understanding and highlights key
knowledge gaps. Findings may inform future research
and the design of mental health policy and interven-
tions in South Africa, other nations in sub-Saharan
Africa, and settings with a high prevalence of conditions,
including HIV, that may be co-morbid with mental
disorders.
Prevalence and epidemiological burden
of MNS disorders in South Africa
Globally, the World Health Organization (WHO) esti-
mates that 30.8% of all years lived with disability (YLDs)
are due to neuropsychiatric disorders, primarily uni-
polar depression (11.9%), alcohol use disorder (3.1%),
schizophrenia (4.8%), and bipolar mood disorder (4.4%)
(18). ThreeMNS disorders (unipolar depressive disorders,
self-inflicted injuries, and alcohol use disorders) are
among the top 20 causes of disability-adjusted life years
(DALYs) lost globally (18, 19), and MNS disorders
account for a larger percentage of lost DALYs than
cardiovascular disease or cancer.
The South African Stress and Health (SASH) Study,
conducted between 2002 and 2004, provides the only
nationally representative data on the prevalence of com-
mon mental disorders (20, 21). Other prevalence studies
examine specific populations and disorders (22, 23), but
do not provide the national representativeness of the
SASH (24). Table 1 shows that lifetime prevalence of
common mental disorders was 30.3%, and prevalence in
the 12 months prior to the survey was 16.5%.
SASH, part of the WHOWorld Mental Health Survey
Initiative, is a cross-national effort to collect country-
specific epidemiological data on mental disorders using a
single assessment tool and data collection methodology.
It includes seven LMICs: China, Columbia, Lebanon,
Mexico, Nigeria, South Africa, and Ukraine. Lifetime
prevalence rates of select types of MNS disorders are
shown in Table 1 (25). Examining all countries surveyed,
the highest lifetime prevalence of these disorders is in the
US and New Zealand (47.4 and 39.3%, respectively)
while the lowest is in Nigeria and China (12.0 and 13.2%,
respectively). South Africa has more than twice the
lifetime prevalence of mental and substance use disorders
than Nigeria (12.0%), the only other African country
surveyed (21, 26), and a greater lifetime prevalence than
all LMICs except Columbia and Ukraine. However, these
comparisons must be interpreted cautiously because
researchers acknowledge that prevalence may be under-
reported in Nigeria and China due to stigma and lack of
public familiarity with surveys (27); prevalence of im-
pulse control disorders are measured in all LMICs except
South Africa, potentially altering the overall prevalence
estimate (25); and the manifestations of mental disorders
and their diagnostic criteria may vary between cultural
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2
(page number not for citation purpose)
Citation: Glob Health Action 2014, 7: 23431 - http://dx.doi.org/10.3402/gha.v7.23431
contexts, making any single diagnostic instrument poten-
tially unfit to capture the range of ways mental disorders
may be expressed (28). In this review, we have chosen to
focus our epidemiological examination only on data from
the WHO World Mental Health Survey to ensure uni-
form data collection methodology and consistency in defi-
nitions of mental disorders. Overall, there are less
epidemiological data on mental disorders than on other
disorders in LMICs and few panel data available to
examine change in their prevalence or burden over time
(29).
The SASH data suggest that the high prevalence
of common mental disorders may be caused by exposure
to stress and trauma during apartheid and the on-
going period of racial tension and inequality following
apartheid (21). The SASH data shows that 74.8% of
South Africans have experienced at least one traumatic
event, most commonly trauma related to someone close
to them (for example, death of a friend or family
member), witnessing a traumatic event, or being the
victim of criminal or intimate partner violence (20).
These traumas and other life stressors, such as economic
hardship and relationship problems, were associated with
increased 12-month and lifetime prevalence of common
mental disorders (30).
In 2000, neuropsychiatric disorders (including mental
and nervous system disorders) ranked third in their
contribution to South Africa’s national burden of disease.
Table 2 shows the contributions of individual MNS
disorders to that burden (31). YLD data was not directly
collected for the country and, consequently, DALY and
YLD estimates must be interpreted cautiously. Suicide,
the only MNS disorder in the top 20 leading causes
of YLLs, ranked thirteenth (1.3%). Suicide causes
5,5147,582 deaths per year (17), with the number of
suicide deaths of people aged under 35 and over 65
increasing between 1968 and 1990 (32).
MNS disorders are commonly co-morbid with HIV,
and the conditions are mutually reinforcing (6, 24, 33).
Considerable research has focused on the high prevalence
of common mental disorders in HIV-positive patients
(3336), with one study reporting that 35% of HIV
patients in South Africa (n100) meet the criteria for
major depressive disorder, 6% for bipolar mood disorder,
and 21% for generalized anxiety disorder (33), far higher
than prevalence estimates for the general population
(24, 33). Among patients with severe mental illness
admitted to a psychiatric hospital (n206), 29.1% were
HIV positive, nearly triple the general population pre-
valence (37). These co-morbidity data may not reflect the
current situation, as they were collected before the rollout
of ARVs and at the tertiary health care level where people
with the most advanced HIV-related disease present for
treatment; those who did not go to the hospital or who
visited primary care clinics were not included.T
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Depression and other mental disorders are of parti-
cular concern in patients with HIV because they can lead
to suboptimal treatment adherence, and consequently,
lower CD4 counts, increased viral load, and a greater
chance of developing drug-resistant strains of HIV that
require more costly second-line anti-retroviral therapy
(38). A diagnosis of HIV also complicates treatment of
MNS disorders because of interactions between antire-
troviral drugs and other medications. Phenobarbital,
for example, a common treatment for epilepsy in sub-
Saharan Africa, substantially reduces the half-life of
some anti-retrovirals, lowering their therapeutic efficacy
(39).
There has been little published research on co-
morbidities between MNS disorders and other chronic dis-
eases, yet existing data from South Africa and elsewhere
in sub-Saharan Africa suggests association between
mental disorders and diabetes, stroke, and epilepsy
(4045).
Service delivery infrastructure
In 2005, South Africa devoted 2.7% of its health budget
to mental health care (19), more than twice that of
Ghana, Uganda, and many other low- to middle-income
countries (46), but less than high-income nations, such as
the UK, which uses 10.8% of its health budget on mental
health. Brazil and India, South Africa’s middle-income
peers, spend 2.38 and 0.06% of their health budgets
on mental health, respectively (47). Mental health care
budget data in the WHO’s Mental Health Atlas was
updated in 2011, but did not include new South African
budget data. Consequently, 2005 data, the most recent
available, is given here for South Africa.
As in many LMICs, the mental health system in
South Africa is fragmented. Mental health care in
South Africa has historically been reliant on psychiatric
hospitals, with little attention to mental health in primary
care (19, 48, 49). Currently, care for psychiatric disorders,
epilepsy and other neurological disorders often occurs
in silos, even at the same health facility, and also varies
from urban to rural areas. For example, epilepsy may be
treated by mental health care providers in rural areas, but
by physical health care providers in urban areas. Sub-
stance use disorders are also treated in both the health
sector and in social development. While the policy is to
develop comprehensive care at a primary care level, this is
not yet fully realized. Importantly, in South Africa, many
people use traditional medicines for MNS disorders,
often before or instead of seeking conventional medical
treatment (50, 51).
With respect to human resources, there is a substantial
mental health workforce shortage, with 1.2 psychiatrists
and 7.5 psychiatric nurses per 100,000 people, nearly
10 times less than many high-income countries. South
Africa’s mental health professionals are concentrated in
urban locations, with some rural provinces having one
or no psychiatrist, leading to great disparities in care
(19, 48).
Review methods
For this narrative overview, we searched Google Scholar
and MEDLINE (using PubMed and Ovid) for articles
written in English on the economic burden of MNS
disorders and for costing data on mental health inter-
ventions in South Africa and other sub-Saharan African
countries. The narrative overview strategy was selected
because it facilitates outlining an area of research that has
previously not been widely discussed and highlights key
theoretical or empirical gaps in the existing knowledge,
yet does not fulfil the methodological criteria of a
systematic review (52). To ensure that results provided a
sufficient and broad overview of the existing knowledge,
we used a deductive approach, generating the paper’s
headings (direct costs, indirect costs, CEAs) then search-
ing for studies that fit those categories. We broadened the
search criteria (from South Africa to sub-Saharan Africa)
if there was little literature from South Africa, a strategy
that would not be appropriate for a systematic review, but
was called for in this case because the amount of
economic data available from South Africa and whether
data from elsewhere in sub-Saharan Africa is general-
izable varies widely between different economic themes
(i.e. direct costs, indirect costs, cost-effectiveness). We
screened the search results for relevant, methodologically
rigorous studies and conducted a forward search of the
references of many of the relevant results to identify
additional studies. Table 3 displays a summary of all of
the studies included in the narrative overview.
Language in South Africa’s mental health policy
focuses on mental health and substance use disorders
Table 2. Contributions of MNS disorders to South Africa’s
burden of disease
MNS disorder
Percentage of
burden of disease
(South Africa)
Ranking in
contribution to
burden of disease
(South Africa)
Unipolar depressive
disorders
5.8 2
Alcohol use 2.8 6
Bipolar mood disorder 2.1 9
Schizophrenia 2.1 11
Drug use 1.6 14
Foetal alcohol syndrome 1.1 16
Obsessive compulsive
disorder
1.0 18
Panic disorder 1.0 19
Source: Norman et al. [31].
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(53), but we broadened the definition to MNS disorders
to include patients with neurological disorders, such as
epilepsy, who are often treated in mental health care
facilities alongside those with mood disorders, anxiety,
schizophrenia, and substance use disorders. Neurological
and substance use disorders are also often co-morbid
with mental disorders and share many of the same co-
morbidities as mental disorders, such as HIV and other
NCDs. Because the mental health system addresses MNS
disorders and these disorders are interlinked, an eco-
nomic analysis would not be complete without attention
to the full burden on the system.
Results
Economic burden of MNS disorders
Economic costs due to mental illness are typically divided
into direct and indirect costs (12, 54). Individuals, govern-
ments, health insurers or other institutions pay direct
costs, usually the costs of medical care and services.
Indirect costs include funds spent or lost as a result of the
condition, including lost productivity for patients and care-
givers, unemployment and disability benefits, and legal,
penal, or other costs related to a crime. While distinguish-
ing direct from indirect costs is useful, there is no defined
reference case for measuring costs and classifying them
as direct or indirect. As a result, there is considerable
methodological variation between studies.
Direct costs
Two studies have explored the direct costs of private,
outpatient chronic disease care in South Africa. One
examined the costs of caring for patients who have private
health insurance with chronic disease benefits and have
been diagnosed with schizophrenia, epilepsy, or bipolar
mood disorder (n210,664 health insurance beneficiaries
receiving treatment for at least one chronic condition*
no specific data on number receiving treatment for other
chronic mental disorders). In 2001, outpatient medical
management (primarily tests, scans, and doctor visits)
for 1 year ranged from R875 (USD$88) for an individual
with bipolar mood disorder to R1200 (USD$120) for
an outpatient with schizophrenia or epilepsy. Medica-
tion costs, on average, are much higher, ranging from
R4362 (USD$436) for patients with epilepsy to R7287
(USD$729) for those with schizophrenia and R7512
(USD$751) for those with bipolar mood disorder (55).
Additionally, based on data from a private sector phar-
maceutical group, in 2008, prescriptions for Alzheimer’s
disease cost an average of R2659 (USD$266) per patient
per year (n588 patients) (56).
Public sector workforce expenditures in LMICs ac-
count for a substantial portion of health care costs (57),
and likely a larger portion of mental health care costs
because mental health services, particularly those with
adequate capacity for psychosocial care, rely less on
laboratory tests or tools and more on trained workers
than other forms of healthcare (2). The estimated work-
force cost of providing integrated adult mental health
services for a limited number of priority mental disorders
using a task-shifting approach (dedicating and support-
ing counsellors and community health workers to work
in mental health rather than hiring more expensive
specialist health mental workers) in primary health care
in South Africa was £28,457 per 100,000 population
(approximately USD$44,200 or USD$0.44 per person in
the population served by the primary health care facility).
The staffing costs of scaling-up integrated primary men-
tal health care, and employing a task-shifting approach
was cheaper than alternative staffing models to provide
comparable care coverage, although the exact cost differ-
ence was not specified (58). The staffing costs associated
with implementing inpatient and outpatient child and
adolescent mental health care ranged from $5.99 per
individual in the population to provide care for 1530%
of children and adolescents with mental disorders to
$21.50 for care for 100% of children and adolescents
with mental disorders (59). A randomized control trial
Table 3. Summary of articles included in the narrative overview
Economic information
available
Number of
studies (total: 18)
Themes
(number of study in parentheses)
Study setting
(number of study in parentheses)
Direct costs 5 Private sector chronic care (2), public sector
workforce costs (2), community interventions (1)
South Africa (5)
Indirect costs 4 Income loss from depression (1), severe mental
disorders (1), hospital stay for mental disorder (1),
and psychological distress (1)
Ghana (1), Kenya (1), Nigeria (1),
and South Africa (1)
Cost-effectiveness 9 Cost-effectiveness of interventions for depression (1),
epilepsy (1), bipolar mood disorder (1), heavy alcohol
use (2), schizophrenia (1), and many mental disorders
(2); cost-effectiveness of group psychotherapy (1)
Low- and middle- income
regions, including sub-Saharan
Africa (7), Nigeria (1), Uganda (1)
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in South Africa examined the effects of home-visits for
recently discharged psychiatric patients (n51) that
aimed to prepare the family for home care and assessed
health status and care over a 1-year period. This inter-
vention reduced re-admission by 31.5% and the number
of days spent in hospital in a year by 55.6%, producing
a cost saving of R786 (approximately USD$79) per
patient (60).
Indirect costs
Indirect costs, i.e. costs to families and households, may
contribute to the total economic burden of mental illness
more than direct costs (54). Only one study has assessed
indirect costs in South Africa, but several have examined
these costs elsewhere in sub-Saharan Africa.
In terms of productivity, the presence of severe depres-
sion or anxiety was associatedwith a reduction in personal
income of USD$4798 per adult per year in South Africa,
resulting in a national loss of USD$3.6 billion annually
(61). In contrast, a Nigerian study found the annual
impact of a severe mental disorder on productivity was
USD$463 per patient, totalling USD$166.2 million an-
nually (62). The disparity in these costs may be due to
differences in purchasing power parity (PPP) between
countries and different measurements of productivity.
Examining the indirect costs of the institutional care
system, a Kenyan study estimated lost productivity over
the course of a hospital stay for patients and their families,
showing that one psychiatric hospital admission resulted
in a USD$453 productivity loss (63). Conversely, house-
hold survey data from Ghana examined the general
population, many of whom lack access to mental health
treatment, and showed that psychological distress,
measured using the Kessler 10 Psychological Distress
Scale (64), was associated with unemployment and lost
work time in both formal and informal sectors. Indivi-
duals with moderate or severe psychological distress
had reductions in productivity of 11.1 and 24.4%, res-
pectively. From these estimates, the researchers calculated
that psychological distress in Ghana is associated with
an approximately 6.8% GDP loss, or USD$2.7 million
annually (65).
Despite research indicating that common mental dis-
orders co-occur with HIV in South Africa (3537), no
studies specify the direct or indirect costs that stem from
the impact that MNS disorders have on other chronic
conditions, including diabetes, and stroke.
CEAs of mental health interventions
Existing research suggests that standard treatments, in-
cluding psychotropic medications and various forms of
psychotherapy, are effective in LMICs (66), and pre-
liminary cost-effectiveness data suggests that they may
also provide good value for money in terms of DALYs
averted.
Several studies examine the cost-effectiveness of inter-
ventions for depression (67), epilepsy (68), bipolar mood
disorder (69), heavy alcohol use (70, 71), and schizophre-
nia (72) in low-income regions, including sub-Saharan
Africa. Using the same methodology, a single study com-
pared the cost-effectiveness of interventions to address
all of these disorders in sub-Saharan Africa. By estimat-
ing staffing, drug, and patient care costs (inpatient stay,
laboratory tests, outpatient visits, medications), the re-
searchers found that national or regional alcohol control
policies (USD$117 per DALY averted by increasing
taxation by 50%) and treatment for epilepsy or depres-
sion in primary care (epilepsy: USD$265 per DALY
averted; depression: USD$858 per DALY averted using
newer anti-depressants) were most cost-effective, while
inpatient care for schizophrenia using newer psychotropic
drugs (USD$11,072 per DALY averted) was least cost-
effective. Treating schizophrenia (USD$2,748 per DALY
averted) and bipolar affective disorder (USD$2,551 per
DALY averted) in the community using older psycho-
tropic drugs paired with psychosocial care was more
cost-effective than inpatient treatment (schizophrenia:
USD$6,816 and bipolar affective disorder: USD$4,874
per DALYaverted). In general, treatments administered in
community and primary care settings were more cost-
effective than those in hospitals. There were substantial
differences in cost-effectiveness between sub-Saharan
African and South East Asian regions, underscoring the
importance of context-specific cost-effectiveness data (73).
Within sub-Saharan Africa, the only country-specific
cost-effective analysis for a range of interventions was
conducted in Nigeria and found approximate corres-
pondence with the regional data in the rank order of
cost-effectiveness of interventions, but differences in the
cost-effectiveness ratios for each intervention (26, 73).
A CEA of group psychotherapy for individuals with
depression in Uganda found that the therapeutic inter-
vention cost $1,150 per quality-adjusted life year added.
The authors concluded that this intervention was cost-
effective because it cost less than Uganda’s per capita
GDP (74), the level that the WHO Commission on
Macroeconomics and Health suggests as the upper limit
for ‘highly cost-effective’ interventions (75). However,
the study’s authors acknowledged that that there is no
universally recognized definition of ‘cost-effectiveness’ or
criteria for what makes an intervention cost-effective in
any given context.
Discussion
This narrative overview examines available costing data
on MNS disorders and the cost-effectiveness of treat-
ments, with a focus on South Africa and data relevant
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to South Africa. In the public sector, there is data on
workforce expenses at a population level for delivery
of specific packages of care (55). In the private sector,
there is information on the costs of medication and
medical management for three severe and chronic mental
disorders (5860). Only one South African study inves-
tigated income reduction associated with depression and
anxiety (61), and few other studies estimate indirect costs
elsewhere in sub-Saharan Africa (62, 63, 65). There are
some region-level data on the cost-effectiveness of inter-
ventions for the treatment and prevention of MNS dis-
orders in sub-Saharan Africa, but no data specific to
South Africa, even though existing analyses suggest
variation in costs and cost-effectiveness between coun-
tries and regions.
What we can conclude from what we know
The data in this review suggests that indirect costs from
foregone income due to MNS disorders are substantial
(6163, 65), and there are cost-effective interventions for
addressing them (73). The most cost-effective interven-
tions incorporate mental health care into primary care
or community services without the use of specialized
workers (5860, 73). Such integration may be particularly
apt in South Africa because of the high and grow-
ing prevalence of MNS disorders co-morbid with HIV
and likely, with other chronic conditions (3, 17, 3537).
Integrated interventions could improve coverage of a
population that is at high risk for mental disorders and
already presenting for care, which would maximize the
impact and cost-effectiveness of interventions and im-
prove overall health outcomes by increasing adherence
to chronic disease treatment regimes.
Prevention interventions that address alcohol consump-
tion by raising taxes, limiting advertising, or reducing
alcohol availability by restricting hours of sale or increas-
ing the drinking age have been shown to be highly cost-
effective interventions for reducing DALYs lost due to
MNS disorders in LMICs (71, 73). The low cost of these
interventions suggests that other prevention programs,
such as campaigns to reduce prevalence of risk factors for
mental disorders (such as child abuse and sexual violence),
may also prove cost-effective.
Knowledge gaps
This review reveals four linked knowledge gaps and
associated methodological challenges.
First, there is inadequate research on the health and
financial burdens of MNS disorders in South Africa
and other LMICs. In terms of health burden, much of
the existing research examines prevalence; this likely
underrepresents the burden of MNS disorders because
of underreporting due to stigma and because much of the
burden is due to disability and premature mortality from
co-morbid conditions or poor lifestyle and self-care (6).
For instance, individuals receiving public mental health
services in the US died 1330 years sooner than people in
the general population, although the causes of death were
similar to those of the general population (76). Premature
mortality in people with mental disorders is not well
understood in LMICs.
While DALY measurements, in theory, illustrate dis-
ability YLD and premature mortality (YLL) more ef-
fectively, consideration must be given to how the DALY
is constructed and measured. DALY estimations in
South Africa use disability weights that are not context-
specific. Disability weighting for YLD calculations varies
widely by context depending on the impact of a given
condition on a person’s lifestyle. In order to develop more
accurate burden measures, disability weights should be
empirically assessed in South Africa and other LMICs,
rather than based on regional data or data from different
countries.
Even DALYs cannot fully capture the societal costs of
mental disorders because they do not take into account
the indirect costs, such as lost productivity of patients
and carers, household resources spent caring for a sick
family member, travel costs for hospital visits, or the nega-
tive impact on patients’ children who may not receive
adequate attention and care. Indirect costs are particu-
larly high for MNS disorders and must be examined
alongside disease burden to fully illustrate their effects
on patients, their families, and the broader society (77).
Furthermore, most direct and indirect cost studies con-
ducted in sub-Saharan Africa examine mental disorders
broadly, with few studies differentiating the costs due to
particular conditions and none specifically examining
costs of neurological and substance use disorders. More
disorder-specific cost data are needed to inform decisions
about priority setting and investment.
Second, although use of traditional medicine for men-
tal disorders is common in South Africa (50, 51), there
are no data on the prevalence of use, motivations for
use, costs, or effectiveness of these treatments. A better
understanding of why people use traditional medicines
and the health effects of a range of traditional practices
would provide insight into beliefs about mental health,
how traditional healing could complement or be inte-
grated with conventional medicine, and whether any
of these practices put patients at risk. Additionally,
existing research on traditional treatments for other
health conditions suggests that the costs for traditional
medicine are high in South Africa, often as high as
those for conventional medical care, and are typically
borne by the poorest segment of the population (78), yet
there is no cost data available on traditional interven-
tions for MNS disorders. Complete, accurate data on
traditional medicines and their costs would provide a
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more thorough picture of mental health care and could
provide a basis for cost-effective, integrated interven-
tions that operate in tandem with existing traditional
practices.
Third, effective strategies for integrating mental health
services into other parts of South Africa’s health system
must be designed and tested. Interventions to incorpo-
rate mental health into primary care and into care for
people living with HIV have shown promise for use in
LMICs (7981), but must be tested in South Africa.
Few interventions that integrate attention to MNS
disorders into treatment programs for other chronic
diseases (82) or blend conventional treatment of MNS
disorders with traditional medicines have been imple-
mented and tested in a LMIC. Before interventions can
be implemented on a national scale, they must be tested
in South Africa and the effectiveness data used to guide
scale-up.
Fourth, in concert with evaluation of the effectiveness
of interventions, there is a need for more data on cost-
effectiveness and the economic impact of a range of
interventions and intervention packages. At present,
cost-effectiveness research primarily examines specific
treatments, rather than care packages, such as coordi-
nated treatment for patients with co-morbid conditions,
prevention efforts integrated with primary health care,
or cooperation with traditional healers. Future cost-
effectiveness studies will need to examine a broader
selection of integrated interventions.
National or provincial cost-effectiveness data may
differ substantially from global or regional findings
and could be important for bringing about changes in
funding priorities (26, 73). For instance, regional cost-
effectiveness data do not fully account for inefficiencies
in South Africa’s fragile health system, such as high
absenteeism and unfilled posts. Furthermore, there is a
need to examine the broader societal benefits, such as
gains in productivity and employment and reduction
in costs to other parts of the economy, for instance,
policing and crime, child protection, or social work
services. Cost-effectiveness data can inform choices on
resource allocation, and information on economic gains
will help with advocacy for mental health services. These
types of economic data are particularly important given
the context of South Africa’s planned implementation
of a national health insurance.
Limitations
The analysis and findings in this review must be acknowl-
edged in light of several limitations. A narrative overview
was selected rather than a systematic review because there
is little economic research related to MNS disorders in
sub-Saharan Africa. As a result, there is great need for an
introduction to the topic that challenges current thinking,
and defines the future research agenda*appropriate
goals for a narrative overview (52). Although the authors
defined the section headings prior to conducting the
search, they took precautions to ensure the presentation
of findings was as unbiased as possible, confining their
commentary and interpretation to the discussion section
and did not generate their arguments until results were
drafted. The grey literature was not searched, and the
authors did not approach the Ministry of Health to get
additional unpublished data. Finally, costing data was
converted to a single currency, but was not adjusted to
account for inflation to preserve the integrity of the
original data.
Conclusion
This narrative overview examines the epidemiological
context of MNS disorders in South Africa and reviews
what is known about their costs and the cost-effectiveness
of their treatments. Existing data suggests that providing
mental health services in the context of other health
interventions and prevention efforts aimed at limiting
alcohol consumption may be most cost-effective. Further
research on the costs related to MNS disorders is greatly
needed to develop an evidence base to support effective
and efficient implementation and advocacy.
Building political will is critical for the implementa-
tion of more integrated models of mental health care.
Economic data will be one key factor in making a per-
suasive case and assisting policymakers to make more
informed choices about the importance of investment
in mental health care and inclusion of mental health in
the basket of options for the proposed national health
insurance. While this review has put forward a set of
potential priorities for researchers to address, further
analysis must be conducted in tandem with conversations
with policymakers able to introduce changes based on
the findings.
Main findings
. South Africa faces a growing burden of mental,
neurological, and substance use (MNS) disor-
ders, which are often co-morbid with HIV and
other chronic diseases. A considerable mental
health treatment gap exists, with significant care
shortages in rural areas.
. Indirect costs, primarily from foregone income
due to MNS disorders, are substantial in sub-
Saharan Africa.
. The most cost-effective treatment interventions
in sub-Saharan Africa incorporate mental health
care into community-based services. Taxation of
alcohol is a ‘‘best buy’’ for prevention.
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